ABO blood groups and risk of human immunodeficiency virus infection: A systematic review and meta-analysis.
ABO blood groups
AIDS
HIV
blood groups
human immunodeficiency virus
systematic review
Journal
Reviews in medical virology
ISSN: 1099-1654
Titre abrégé: Rev Med Virol
Pays: England
ID NLM: 9112448
Informations de publication
Date de publication:
05 2022
05 2022
Historique:
revised:
10
09
2021
received:
15
08
2021
accepted:
12
09
2021
pubmed:
1
10
2021
medline:
20
5
2022
entrez:
30
9
2021
Statut:
ppublish
Résumé
The last few decades have seen a pandemic of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), which continues to cause substantial morbidity and mortality. ABO blood groups are anthropological and genetic characteristics of a population whose associations with HIV infection are still controversial. This systematic review with meta-analysis was undertaken to investigate whether certain blood groups may have associations with HIV infection. PubMed, Scopus and Web of Science databases were systematically searched as of 6 September 2021. Grey literature was identified through screening Google Scholar, and reference lists of relevant studies. All observational studies providing data on ABO blood group distribution among HIV-infected and uninfected participants were included. Using a random effect model, risk ratios (RR) and 95% confidence intervals (CIs) were pooled to quantify this relationship. Fifty eligible studies with a total of 3,068,244 participants and 6508 HIV-infected cases were included. The overall analysis found that blood group AB increased the risk of HIV infection by 19% as compared with non-AB blood groups (RR = 1.19, 95% CI: 1.03-1.39, p = 0.02). Pooled estimates for other blood groups failed to reach statistical significance. Subgroup analyses identified a positive relationship between AB blood group and HIV infection within Asia, patient populations (as opposed to blood donors and general populations), studies with lower sample sizes, high-income countries and studies with a moderate quality score. The sequential omission and re-analysis of studies within sensitivity analyses produced no change in the overall pooled effect. In conclusion, this study identified that blood group AB carriers were more susceptible to HIV infection. Future investigations should be directed toward clarification of the exact role of ABO blood groups in HIV infection and the possible underlying mechanisms.
Substances chimiques
ABO Blood-Group System
0
Types de publication
Journal Article
Meta-Analysis
Review
Systematic Review
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e2298Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
Frank TD, Carter A, Jahagirdar D, et al. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: a systematic analysis for the global burden of diseases, injuries, and risk factors study 2017. Lancet HIV. 2019;6:e831-e859. doi:10.1016/S2352-3018(19)30196-1
Sinopoli A, Isonne C, Santoro MM, Baccolini V. The effects of orally administered lactoferrin in the prevention and management of viral infections: a systematic review. Rev Med Virol. 2021;28:e2261. doi:10.1002/rmv.2261
Abioye AI, Bromage S, Fawzi W. Effect of micronutrient supplements on influenza and other respiratory tract infections among adults: a systematic review and meta-analysis. BMJ Glob Health. 2021;6:e003176. doi:10.1136/bmjgh-2020-003176
Estimated number of people (all ages) living with HIV. World Health Organization (WHO). 2021. Accessed January 9, 2021. https://www.who.int/data/gho/data/indicators/indicator-details/GHO/estimated-number-of-people-(all-ages)-living-with-hiv
Dwyer-Lindgren L, Cork MA, Sligar A, et al. Mapping HIV prevalence in sub-Saharan Africa between 2000 and 2017. Nature. 2019;570:189-193. doi:10.1038/s41586-019-1200-9
Hutchinson AB, Farnham PG, Dean HD, et al. The economic burden of HIV in the United States in the era of highly active antiretroviral therapy: evidence of continuing racial and ethnic differences. JAIDS J Acquir Immune Defic Syndromes. 2006;43:451-457. doi:10.1097/01.qai.0000243090.32866.4e
Czerwiński M. Blood groups - minuses and pluses. Do the blood group antigens protect us from infectious diseases? Postepy Hig Med Dosw. 2015;69:703-722. doi:10.5604/17322693.1158795
Table of blood group systems. International Society of Blood Transfusion (ISBT). 2021. Accessed January 9, 2021. https://www.isbtweb.org/
Blood type frequencies by country including the Rh factor. Rh Negative Blood and People. 2021. Accessed January 9, 2021. http://www.rhesusnegative.net/themission/bloodtypefrequencies/
Rowe JA, Opi DH, Williams TN. Blood groups and malaria: fresh insights into pathogenesis and identification of targets for intervention. Curr Opin Hematol. 2009;16:480-487. doi:10.1097/MOH.0b013e3283313de0
Cooling L. Blood groups in infection and host susceptibility. Clin Microbiol Rev. 2015;28:801-870. doi:10.1128/cmr.00109-14
Mohammadali F, Pourfathollah A. Association of ABO and Rh blood groups to blood-borne infections among blood donors in Tehran-Iran. Iran J Public Health. 2014;43:981-989.
Onsten TG, Callegari-Jacques SM, Goldani LZ. The higher frequency of blood group B in a Brazilian population with HIV infection. Open AIDS J. 2013;7:47-50. doi:10.2174/1874613601307010047
Obead RF, Utba NM. Descriptive analysis of Iraqi HIV-infected patients. Plant Archiv. 2020;20:265-269.
Otori NM, Aminu M. Mukhtar HM, Ocheme Julius O. Predominant blood group antigen and risk factors associated with HIV infection among HIV positive patients in Zaria, Kaduna State, Nigeria. Int J Pharm Chem Biol Sci. 2013;3:1052-1060.
Prakash S, Sahoo D, Mishra D, et al. Association of transfusion transmitted infections with ABO and Rh D blood group system in healthy blood donors: a retrospective analysis. Int J Commun Med Pub Health. 2020;7:1.
Sharma P, Chaurasia R, Singh P. Distribution of transfusion transmitted infections in ABO and Rh blood groups: a 5 year study. Ann Int Med Dent Res. 2017:2. doi:10.21276/aimdr.2017.3.5.PT5
Siransy LK, Nanga ZY, Zaba FS, Tufa NY, Dasse SR, ABO/Rh blood groups and risk of HIV infection and hepatitis B among blood donors of Abidjan. Cote D'ivoire. Eur J Microbiol Immunol. 2015;5:205-209. doi:10.1556/1886.2015.00029
Ukaejiofo EO, Nubila T. Association between ABO, Rhesus blood group systems and haemoglobin genotype among confirmed HIVAIDS-TB co-infected patients in Enugu Urban, Nigeria. W Afr J Med. 2006;25:61-64.
Nkenfou CN, Nkenfou CN, Tiedeu BA, Mbanya D. ABO-Rhesus blood groups and susceptibility to HIV infection. J Pharm Chem Biol Sci. 2015;3:324-328.
Joshi SK, Ghimire GR. Serological prevalence of antibodies to human immunodeficiency virus (HIV) and hepatitis B virus (HBV) among healthy Nepalese males-a retrospective study. Kathmandu Univ Med J. 2003;1:251-255.
Abdulazeez AA, Alo EB, Rebecca SN. Carriage rate of human immunodeficiency virus (HIV) infection among different ABO and Rhesus blood groups in Adamawa state, Nigeria. Biomed Res. 2008;19:41-44.
Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology. A proposal for reporting. J Am Med Assoc. 2000;283:2008-2012. doi:10.1001/jama.283.15.2008
Rostam A, Dube C, Cranney A. Appendix D. Quality Assessment Forms. Agency for healthcare research and quality (US). 2004. https://www.ncbi.nlm.nih.gov/books/NBK35156/
HIV/AIDS - adult prevalence rate - The World Factbook. Accessed January 9, 2021. https://www.cia.gov/the-world-factbook/field/hiv-aids-adult-prevalence-rate/country-comparison
Kenyon C, Buyze J. Should the threshold for a generalised HIV epidemic be 1% or 5%? Int J STD AIDS. 2014;25:898-900. doi:10.1177/0956462414526575
The world by income and region. Accessed January 9, 2021. https://datatopics.worldbank.org/world-development-indicators/the-world-by-income-and-region.html
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
Flax S, Blackall D. The A(1) blood group antigen is decreased in AIDS patients with systemic fungal or bacterial infections. Blood. 1997;90:3297.
Fulman M, Kim J, Distenfeld A. ABO and RH blood groups distribution in HIV(+) patients. Blood. 1997;90:2935.
Kyriakides T, Eleftheriou A, Michaelides N, Papantoniou L. Surveillance of HIV in the army of the Republic of Cyprus (SHARC); rationale, design, and implementation of an inexpensive system. Sex Transm Infect. 2002;78:50-52. doi:10.1136/sti.78.1.50
Jeremiah ZA, Okon IA, Jeremiah TA. Seroprevalence of HIV and frequencies of haemoglobin genotypes, ABO and Rh blood groups, among premarital couples in Port Harcourt, Nigeria. S Afr Fam Pract. 2007;49:15-15d. doi:10.1080/20786204.2007.10873509
Alii JA, Okonko IO, Abraham OA, et al. A serosurvey of blood parasites (Plasmodium, microfilaria, HIV, HBsAG, HCV antibodies) in prospective Nigerian blood donors. Res J Med Sci. 2010;4:255-275. doi:10.3923/rjmsci.2010.255.275
Safi SZ, Afzal MS, Waheed Y, et al. Seroprevalence of hepatitis C and human immunodeficiency viruses in blood donors of northwestern Pakistan. Asian Biomed. 2011;5:389-392. doi:10.5372/1905-7415.0503.049
Osazuwa F, Obinna O, Yusuf AO. Sero-prevalence of human immunodeficiency virus, B and C viruses among intending blood donors atten university of Abuja teaching hospital, Gwagwalada. Fct Abuja Niger New Iraqi J Med. 2012;8:27-32.
Ravi Kumar M, Srinivasa Rao M, Pulicherla KK, et al. Studies on the distribution of hepatitis B (HBV) and human immunodeficiency virus (HIV) - their relation to blood groups and rhesus (RH) factor in Guntur district of Andhra Pradesh, India. Asian J Pharm Clin Res. 2013;6:109-111.
Osaro E, Mohammed N, Zama I, et al. Prevalence of p24 antigen among a cohort of HIV antibody negative blood donors in Sokoto, northwestern Nigeria - the question of safety of blood transfusion in Nigeria. Pan Afr Med J. 2014;18:18. doi:10.11604/pamj.2014.18.174.3449
Chanzu NM, Mwanda W, Oyugi J, Anzala O. Mucosal blood group antigen expression profiles and HIV infections: a study among female sex workers in Kenya. Plos One. 2015;10:10. doi:10.1371/journal.pone.0133049
Beck GA, Vermeulen M, Chowdhury D, et al. ABO and RhD blood groups and susceptibility to HIV infection among South African blood donors. Transfusion. 2016;56:186A.
Lakshmi VS, Devarashetty SP, Borugadda N, Kumar T. A study of seroprevalence of transfusion transmitted infections (TTIS) in blood donors of Anantapur district in Andhra Pradesh. J Evol Med Dent Sci. 2016;5:5456-5458. doi:10.14260/jemds/2016/1235
Motswaledi MS, Kasvosve I, Oguntibeju OO. Blood group Antigens C, Lub, P1 may have a role in HIV infection in Africans. Plos One. 2016;11:11. doi:10.1371/journal.pone.0149883
Ekinci O, Kara O, Dogan A, Demircioglu S, Demir C. Distribution of ABO and Rh blood groups and seroprevalence of HBSAG, anti-HCV, anti-HIV and syphilis in healthy donors: a single center experience. Leukemia Res. 2017;61:S27.
Haq MFU, Gohar A, Humza MS, Lodhi AA, Akram S, Shahid S. Blood donors awareness to know their blood group and prevalence of HIV, HBsAg and anti HCV screening at Dharampura district Lahore. Pak J Med Health Sci. 2017;11:1518-1520.
Alaidarous M, Choudhary RK, Waly MI, et al. The prevalence of transfusion-transmitted infections and nucleic acid testing among blood donors in Majmaah, Saudi Arabia. J Infect Publ Health. 2018;11:702-706. doi:10.1016/j.jiph.2018.04.008
Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. BMC Publ Health. 2018;18:18. doi:10.1186/s12889-018-5555-x
Aabdien M, Selim N, Himatt S, et al. Prevalence and trends of transfusion transmissible infections among blood donors in the State of Qatar, 2013-2017. BMC Infect Dis. 2020;20:20. doi:10.1186/s12879-020-05344-5
Alabdulmonem W, Shariq A, Alqossayir F, et al. Sero-prevalence ABO and Rh blood groups and their associated transfusion-transmissible infections among blood donors in the central region of Saudi Arabia. J Infect Publ Health. 2020;13:299-305. doi:10.1016/j.jiph.2019.12.004
Arendrup M, Hansen JE, Clausen H, Nielsen C, Mathiesen LR, Nielsen JO. Antibody to histo-blood group A antigen neutralizes HIV produced by lymphocytes from blood group A donors but not from blood group B or O donors. AIDS. 1991;5:441-444. doi:10.1097/00002030-199104000-00014
Blackwell CC, James VS, Davidson S, et al. Secretor status and heterosexual transmission of HIV. Br Med J. 1991;303:825-826. doi:10.1136/bmj.303.6806.825-a
Glinsky GV. The blood-group antigen-related glycoepitopes - key structural determinants in immunogenesis and aids pathogenesis. Med Hypotheses. 1992;39:212-224. doi:10.1016/0306-9877(92)90112-p
Hansen JES, Clausen H, Hu SL, Nielsen JO, Olofsson S. An O-linked carbohydrate neutralization epitope of HIV-1 GP 120 IS expressed by HIV-1 ENV gene recombinant vaccinia virus. Arch Virol. 1992;126:11-20. doi:10.1007/bf01309680
Friedli F, Rieben R, Wegmuller E, Moerenhout M, Nydegger UE. Normal levels of allo- but increased levels of potentially autoreactive antibodies against ABO histo-blood group antigens in AIDS patients. Clin Immunol Immunopathol. 1996;80:96-100. doi:10.1006/clin.1996.0099
Moulds JM, Nowicki S, Moulds JJ, Nowicki BJ. Human blood groups: Incidental receptors for viruses and bacteria. Transfusion. 1996;36:362-374. doi:10.1046/j.1537-2995.1996.36496226154.x
Ali S, Niang MA, N'Doye I, et al. Secretor polymorphism and human immunodeficiency virus infection in Senegalese women. J Infect Dis. 2000;181:737-739. doi:10.1086/315234
Gustafsson K, Durrbach A, Seymour RM, Pomiankowski A. The role of ABO histo-blood group antigens in viral infections. Trends Glycosci Glycotechnol. 2005;17:285-294. doi:10.4052/tigg.17.285
Neil SJ, McKnight A, Gustafsson K, Weiss RA. HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation. Blood. 2005;105:4693-4699. doi:10.1182/blood-2004-11-4267
Kindberg E, Hejdeman B, Bratt G, et al. A nonsense mutation (428G>A) in the fucosyltransferase FUT2 gene affects the progression of HIV-1 infection. AIDS. 2006;20:685-689. doi:10.1097/01.aids.0000216368.23325.bc
Beck Z, Brown BK, Wieczorek L, et al. Human erythrocytes selectively bind and enrich infectious HIV-1 virions. Plos One. 2009;4:4. doi:10.1371/journal.pone.0008297
Anstee DJ. The relationship between blood groups and disease. Blood. 2010;115:4635-4643. doi:10.1182/blood-2010-01-261859
Azad MB, Wade KH, Timpson NJ. FUT2 secretor genotype and susceptibility to infections and chronic conditions in the ALSPAC cohort. Wellcome Open Res. 2018;3:65. doi:10.12688/wellcomeopenres.14636.2
Rios M, Bianco C. The role of blood group antigens in infectious diseases. Seminars Hematol. 2000;37:177-185. doi:10.1016/s0037-1963(00)90042-8
Branch DR. Blood groups and susceptibility to virus infection: new developments. Curr Opin Hematol. 2010;17:558-564. doi:10.1097/MOH.0b013e32833ece31
Motswaledi MS, Kasvosve I, Oguntibeju OO. The role of red blood cells in enhancing or preventing HIV infection and other diseases. Biomed Res Int. 2013;2013:2013-2017. doi:10.1155/2013/758682
Johnston RE, Heitzeg MM. Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review. AIDS Res Hum Retroviruses. 2015;31:85-97. doi:10.1089/aid.2014.0205
Heggelund JE, Varrot A, Imberty A, Krengel U. Histo-blood group antigens as mediators of infections. Curr Opin Struct Biol. 2017;44:190-200. doi:10.1016/j.sbi.2017.04.001
Davison GM, Hendrickse HL, Matsha TE. Do blood group antigens and the red cell membrane influence human immunodeficiency virus infection? Cells. 2020;9:9. doi:10.3390/cells9040845
Lack of transmission of human immunodeficiency virus through Rho(D) immune globulin (human). Morb Mortal Weekly Rep 1987;36:728-729.
Bierling P, Karianakis G, Duedari N, et al. Anti-rhesus antibodies, immune thrombocytopenia, and human immunodeficiency virus treatment. Ann Intern Med. 1987;106:773-774. doi:10.7326/0003-4819-106-5-773_3
Heymann SJ, Brewer TF. The problem of transfusion-associated acquired immunodeficiency syndrome in Africa: a quantitative approach. Am J Infect Control. 1992;20:256-262. doi:10.1016/s0196-6553(05)80199-3
Ankouane F, Noah DN, Atangana MM, Simo RK, Guekam PR, Sida MB. Seroprevalence of hepatitis B and C viruses, HIV-1/2 and syphilis among blood donors in the Yaounde Central Hospital in the centre region of Cameroon. Transfus Clinique Biol. 2016;23:72-77. doi:10.1016/j.tracli.2015.11.008
Ngassaki-Yoka CD, Ndong JMN, Bisseye C. ABO, blood groups rhesus and transfusion-transmitted infections among blood donors in Gabon. Sudan J Med Sci. 2018;13:12-21. doi:10.18502/sjms.v13i1.1685
Abate M, Wolde T. Seroprevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis among blood donors at Jigjiga blood bank, Eastern Ethiopia. Ethiop J Health Sci. 2016;26:155-162. doi:10.4314/ejhs.v26i2.9
Amidu N, Owiredu WBKA, Addai-Mensah O, Alhassan A, Quaye L, Batong B. Seroprevalence and risk factors for human immunodeficiency virus, Hepatitis B and C viruses infections among blood donors at the Bolgatanga Regional Hospital in Bolgatanga, Ghana. J Ghana Sci Assoc. 2010;12(1). doi:10.4314/jgsa.v12i1.56794
Bamisaye E, Adepeju A, Akanni E, Akinbo D, Omisore A. Association between blood group Antigens, CD4 cell count and haemoglobin electrophoretic pattern in HIV infection. Int J Life Sci Scienti Res. 2017;3:1300-1304.
Basey E. Relationship between ABO blood groups/rhesus factor and risk of human immuno deficiency virus (HIV) infection. Int J Agric Biosci. 2013;2:383-385.
Biadgo B, Hassen A, Getaneh M, et al. Syphilis and human immunodeficiency virus infections among pregnant women attending antenatal care clinic of Gondar family guidance association, Northwest Ethiopia: implication for prevention of mother to child transmission. Reprod health. 2019;16:1-8.
Bisetegen FS, Bekele FB, Ageru TA, Wada FW. Transfusion-transmissible infections among voluntary blood donors at Wolaita Sodo university teaching referral hospital, South Ethiopia. Can J Infect Dis Med Microbiol. 2016;2016:2016-6. doi:10.1155/2016/8254343
Buseri FI, Okonkwo CN. Abnormal hemoglobin genotypes and ABO and rhesus blood groups associated with HIV infection among HIV-exposed infants in northwestern Nigeria. Pathology Laboratory Med Int. 2014;6:15-20. doi:10.2147/plmi.s61046
Damulak O, Bolorunduro S, Egesie J, et al. Discordant sero-positive HIV antigen/antibody assays among voluntary blood donors in North Central Nigeria. 2013.
Davison GM, Hendrickse HL, Matsha TE. The relationship between immunogenic red blood cell antigens and human immunodeficiency virus infection. Transfus Apher Sci. 2018;57:58-62. doi:10.1016/j.transci.2017.11.033
Dirisu JO, Alli TO, Adegoke AO, Osazuwa FA. Survey of prevalence of serum antibodies to human immunodeficiency deficiency virus (HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) among blood donors. N Am J Med Sci. 2011;3:35-38. doi:10.4297/najms.2011.335
Eteng M, Otu D, Ochalefu D, Amali O, Obochi G, Myke-Mbata B. Susceptibility of human blood groups to human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections. Niger Ann Pure Appl Sci. 2015;6:35-40.
Eze KA, Ogundeji EB, Nwuko AC, et al. Immunoglobulin levels in HIV patients and ABO blood group: is there a relationship? J Med Physiol Biophys. 2014;5:100-105.
Ezeugwunne I, Ogbodo E, Oguaka V, et al. The prevalence of ABO blood groups, genotypes, marital status and levels of education of adults HIV positive males in Nnewi, Nigeria. IOSR J Dent Med Sci. 2018;17(1):69-75.
Igbeneghu C, Odaibo G, Olisekodiaka J, Folarin O, Oseni B. ABO blood group and secretor status in HIV infection in Osogbo, Southwestern Nigeria. Eur J Res Med Sci. 2015;3:1-7.
Luksamijarulkul P, Thammata N, Tiloklurs M. Seroprevalence of Hepatitis B, Hepatitis C and human immunodeficiency virus among blood donors, Phitsanulok Regional Blood Center, Thailand. South Asian J Trop Med Publ Health. 2002;33:272-279.
Mercy O, Obeagu E, Nnokam N. Association of ABO blood group with HIV infection. J Infect Dis Med Microbiol. 2020;1(1):1-7.
Ndeh FJ, Asemota EA, Okpokam DC, Ekeagba II. ABH substances secretion status, ABO & rhesus blood groups typing and P24 antigen screening in HIV 1 and 2 screened antibody-negative apparently healthy prospective blood donors in Calabar, Nigeria. Int J Res Rep Hematol. 2020:1-25.
Nneli R, Ekpo B, Ohaeri O, Egene J. Prevalence of Rh and ABO blood groups in HIV seropositive pregnant women in Enugu, Nigeria. Niger J Physiological Sci. 2004;19:7-9.
Sube KL, Seriano OF, Gore RP, et al. Prevalence of HIV among blood donors at juba teaching hospital blood Bank, South Sudan. S Sudan Med J. 2014;7:76-80.
Umolu PI, Okoror LE, Orhue P. Human immunodeficiency virus (HIV) seropositivity and hepatitis B surface antigenemia (HBSAG) among blood donors in Benin city, Edo state, Nigeria. Afr Health Sci. 2005;5:55-58.
Ahmad T, Nadeem M, Khan FU, Uddin S, Maqsood-Ur-Rehman M, Anwar N. Incidence of HBV, HCV and HIV among blood donors from Peshawar KPK, Pakistan. Population. 2017;6:19.
Almaiman AA, Almaiman SH. Evaluation of blood donors and transfusion transmitted infections and their association with ABO and Rh blood groups in Unaizah, Saudi Arabia: a retrospective study. Int J Med Res Health Sci. 2018;7:143-150.
Al-Nafakh RT, Al-Fadhul SAL, Al-Sherees HAA, Al-Charrakh AH. Seroprevalence of HBV, HCV, and HIV among blood donors in main blood bank in Najaf Province, Iraq. Ind J Publ Health Res Develop. 2019;10:385-390. doi:10.5958/0976-5506.2019.00723.X
Arif SH, Saeed N, Alam K. Association of ABO and Rh blood group with transfusion transmitted infections (TTI) among blood donors in north India. J Blood Disord Transfus. 2019;8:271-275.
Banu A, Ahmed S, Shastri S. Distribution of Abo and Rh blood groups in HIV seropositives at an integrated counseling and testing centre in Karnataka, India. SAARC J Tuberc Lung Dis HIV/AIDS. 2011;8:42-45.
Batool Z, Durrani SH, Tariq S. Association of ABO and Rh blood group types to hepatitis B, hepatitis C, HIV and syphilis infection, a five year' experience in healthy blood donors in a tertiary care hospital. J Ayub Med Coll Abbottabad JAMC. 2017;29:90-92.
Bharadva S, Vachhani J, Dholakiya S. ABO and Rh association to transfusion transmitted infections among healthy blood donors in Jamnagar, Gujarat, India. J Res Med Dent Sci. 2016;4:58-62. doi:10.5455/jrmds.20164113
Farhud D. ABO and Rh blood groups distribution in Hemophilia and anti-HIV positive individuals. Iran J Publ Health. 1987;16:1-8.
Hroob AM, Saghir SAM, Almaiman AA, et al. Prevalence and association of transfusion transmitted infections with ABO and Rh blood groups among blood donors at the national blood bank, Amman, Jordan. Medicina-Lithuania. 2020;56:701. doi:10.3390/medicina56120701
Konuri S, Rao K, Ausavi S, Sivaraj N, Siraz M. Incidence of HIV, HBV and HCV infections and association of ABO and Rh blood groups with these infections among blood donors in tertiary care hospital of coastal area of Andhra Pradesh: A retrospective study. 2019. doi:10.26611/1008531
Mandal K, Roy SK, Mandal K. Seroprevalence of transfusion transmitted infection (TTI) among healthy blood donor and their distribution within blood groups-a study from Kolkata. JMSCR. 2015;3:3799-3805.
Mandodar L, Shetty A, Chowdappa V. Distribution of ABO, rhesus blood groups, transfusion transmitted diseases and adverse donor reactions in a blood bank of a tertiary care hospital: a five year study. Natl J Lab Med. 2016;5(3):26-30.
Memon FA, Ujjan ID, Memon AI, Shaikh AR, Rao AR, Naz A. Seroprevalence of transfusion transmitted infections among different blood group donors at Blood Bank LUMHS, Hyderabad. Pak J Med Sci. 2017;33:443-446. doi:10.12669/pjms.332.11691
Nigam JS, Singh S, Kaur V, Giri S, Kaushal RP. The prevalence of transfusion transmitted infections in ABO blood groups and Rh type system. Hematol Rep. 2014;6:71-72. doi:10.4081/hr.2014.5602
Sayal SK, Das AL, Nema SK. Study of blood groups in HIV seropositive patients. Indian J Dermatol Venereol Leprol. 1996;62:295-297.
Tyagi S, Tyagi A. Possible correlation of transfusion transmitted diseases with Rh type and ABO blood group system. J Clin Diagnostic Res. 2013;7:1930-1931. doi:10.7860/jcdr/2013/6002.3360
Zeeshan M, Anwar F. Ali Shah I. Prevalence of HBV, HCV, HIV and syphilis in blood donor at Mardan Medical complex. Khyber Pakhtunkhwa, Pakistan. Int J Biosci. 2018;12(5):297-303.
Bodmer W. Genetic characterization of human populations: from ABO to a genetic map of the British people. Genetics. 2015;199:267-279. doi:10.1534/genetics.114.173062
Amjadi O, Rafiei A, Ajami A, Valadan R, Janbaabaei G. Blood groups: in health and diseases. Res Mol Med. 2015;3:1-9. doi:10.7508/rmm.2015.04.001
He M, Wolpin B, Rexrode K, et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol. 2012;32:2314-2320. doi:10.1161/atvbaha.112.248757
Kamil M, Al-Jamal HAN, Yusoff NM. Association of ABO blood groups with diabetes mellitus. Libyan J Med. 2010;5:10. doi:10.3402/ljm.v5i0.4847
Alexander KS, Zakai NA, Gillett S, et al. ABO blood type, factor VIII, and incident cognitive impairment in the REGARDS cohort. Neurol. 2014;83:1271-1276. doi:10.1212/wnl.0000000000000844
Huang JY, Wang R, Gao YT, Yuan JM. ABO blood type and the risk of cancer - findings from the Shanghai Cohort Study. PLoS One. 2017;12:e0184295. doi:10.1371/journal.pone.0184295
Goel R, Bloch EM, Pirenne F, et al. ABO blood group and COVID-19: a review on behalf of the ISBT COVID-19 working group. Vox Sang. 2021;116:849-861. doi:10.1111/vox.13076
Zhang Y, Garner R, Salehi S, La Rocca M, Duncan D. Association between ABO blood types and coronavirus disease 2019 (COVID-19), genetic associations, and underlying molecular mechanisms: a literature review of 23 studies. Ann Hematol. 2021;100:1123-1132. doi:10.1007/s00277-021-04489-w
Pendu JL, Breiman A, Rocher J, Dion M, Ruvoën-Clouet N. ABO blood types and COVID-19: spurious, anecdotal, or truly important relationships? A reasoned review of available data. Viruses. 2021;13:160.
Shokri P, Golmohammadi S, Noori M, Nejadghaderi SA, Carson-Chahhoud K, Safiri S. The relationship between blood groups and risk of infection with SARS-CoV-2 or development of severe outcomes: a review. Rev Med Virology. 2021. doi:10.1002/rmv.2247
Yanardag Acik D, Bankir M. Relationship of SARS-CoV-2 pandemic with blood groups. Transfus Med Hemother. 2021;48:161-167. doi:10.1159/000515609
Degarege A, Gebrezgi MT, Ibanez G, Wahlgren M, Madhivanan P. Effect of the ABO blood group on susceptibility to severe malaria: a systematic review and meta-analysis. Blood Rev. 2019;33:53-62. doi:10.1016/j.blre.2018.07.002
Liao Y, Xue L, Gao J, Wu A, Kou X. ABO blood group-associated susceptibility to Norovirus infection: a systematic review and meta-analysis. Infect Genet Evol. 2020;81:104245. doi:10.1016/j.meegid.2020.104245
Jing W, Zhao S, Liu J, Liu M. ABO blood groups and hepatitis B virus infection: a systematic review and meta-analysis. BMJ open. 2020:10.e034114.
Hashan MR, Ghozy S, El-Qushayri AE, Pial RH, Hossain MA, Al Kibria GM. Association of dengue disease severity and blood group: a systematic review and meta-analysis. Rev Med Virol. 2020.e2147.
Harris JB, Khan AI, LaRocque RC, et al. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun. 2005;73:7422-7427. doi:10.1128/iai.73.11.7422-7427.2005
Huang P, Farkas T, Marionneau S, et al. Noroviruses bind to human ABO, Lewis, and secretor histo-blood group antigens: identification of 4 distinct strain-specific patterns. J Infect Dis. 2003;188:19-31. doi:10.1086/375742
Aspholm-Hurtig M, Dailide G, Lahmann M, et al. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science. 2004;305:519-522. doi:10.1126/science.1098801
Chen L, Xiong J, Bao L, Shi Y. Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis. 2020;20:398-400.
Navas EL, Venegas MF, Duncan JL, Anderson BE, Chmiel JS, Schaeffer AJ. Blood group antigen expression on vaginal and buccal epithelial cells and mucus in secretor and nonsecretor women. J Urol. 1993;149:1492-1498. doi:10.1016/s0022-5347(17)36425-x
Kelly RJ, Rouquier S, Giorgi D, Lennon GG, Lowe JB. Sequence and expression of a candidate for the human Secretor blood group alpha(1,2)fucosyltransferase gene (FUT2). Homozygosity for an enzyme-inactivating nonsense mutation commonly correlates with the non-secretor phenotype. J Biol Chem. 1995;270:4640-4649. doi:10.1074/jbc.270.9.4640
Fontanet AL, Messele T, Dejene A, et al. Age- and sex-specific HIV-1 prevalence in the urban community setting of Addis Ababa, Ethiopia. AIDS. 1998;12(3):315-322. doi:10.1097/00002030-199803000-00010
Vigliotti V, Taggart T, Walker M, Kusmastuti S, Ransome Y. Religion, faith, and spirituality influences on HIV prevention activities: a scoping review. Plos One. 2020;15:e0234720. doi:10.1371/journal.pone.0234720